1-3 of 3
Ifeorah Chizoba, MPH
Close
Sort by
Journal Articles

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Cenk Yildirim, MS, Aimaz Afrough, MD, Adanma Anji Ayanambakkam Attanathi, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1806.
https://doi.org/10.1182/blood-2019-132227
Published: 2019
Journal Articles

With Equal Access, African Americans with Non-del17p Multiple Myeloma Have Superior Overall Survival, but del17p Still Carries Poor Prognosis across Race: A VA Study

Anusha Munjuluri, MSc, Nathanael Fillmore, PhD, Diana Cirstea, MD, Hassan Yameen, MD, Sarvari Venkata Yellapragada, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4388.
https://doi.org/10.1182/blood-2019-131247
Published: 2019
Journal Articles

Vitamin D Deficiency Predicts for Poor Overall Survival in Caucasian but Not African American Patients with Multiple Myeloma

Sarvari Venkata Yellapragada, MD, Anna Frolov, M.S., M.A, Nathanael Fillmore, PhD, Pallavi Dev, Sumaira Shafi, MD, Ifeorah Chizoba, MPH, Do Nhan, MD, Do T Nhan, MD, Nikhil Munshi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1890.
https://doi.org/10.1182/blood-2018-99-117268
Published: 2018